150 related articles for article (PubMed ID: 9196279)
1. Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels.
Valenzuela C; Delpón E; Franqueza L; Gay P; Vicente J; Tamargo J
Eur J Pharmacol; 1997 May; 326(2-3):257-63. PubMed ID: 9196279
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of the antihistamines epinastine, terfenadine, and ebastine on potassium currents in rat ventricular myocytes.
Ohtani H; Hanada E; Hirota M; Sato H; Kotaki H; Sawada Y; Uemura H; Nakaya H; Iga T
J Pharm Pharmacol; 1999 Sep; 51(9):1059-63. PubMed ID: 10528990
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of loratadine and terfenadine on cardiac K+ channels.
Ducic I; Ko CM; Shuba Y; Morad M
J Cardiovasc Pharmacol; 1997 Jul; 30(1):42-54. PubMed ID: 9268220
[TBL] [Abstract][Full Text] [Related]
4. Suppression of mammalian K+ channel family by ebastine.
Ko CM; Ducic I; Fan J; Shuba YM; Morad M
J Pharmacol Exp Ther; 1997 Apr; 281(1):233-44. PubMed ID: 9103502
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological study of ebastine, a novel histamine H1-receptor antagonist].
Yakuo I; Ishii K; Seto Y; Imano K; Takeyama K; Nakamura H; Karasawa T
Nihon Yakurigaku Zasshi; 1994 Mar; 103(3):121-35. PubMed ID: 7511558
[TBL] [Abstract][Full Text] [Related]
6. [The effect of second generation histamine antagonists on the heart].
Grzelewska-Rzymowska I; Pietrzkowicz M; Górska M
Pneumonol Alergol Pol; 2001; 69(3-4):217-26. PubMed ID: 11575008
[TBL] [Abstract][Full Text] [Related]
7. Towards the optimal antihistamine: studies with ebastine.
Roberts DJ
Inflamm Res; 1998; 47 Suppl 1():S36-7. PubMed ID: 9561405
[No Abstract] [Full Text] [Related]
8. Effects of histamine H1 receptor antagonists on action potentials in guinea-pig isolated papillary muscles.
Ki I; Inui A; Ito T
Arch Int Pharmacodyn Ther; 1996; 331(1):59-73. PubMed ID: 8896711
[TBL] [Abstract][Full Text] [Related]
9. Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval.
Malik M
Br J Clin Pharmacol; 2002 Dec; 54(6):682-3. PubMed ID: 12492623
[No Abstract] [Full Text] [Related]
10. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine.
Roy M; Dumaine R; Brown AM
Circulation; 1996 Aug; 94(4):817-23. PubMed ID: 8772706
[TBL] [Abstract][Full Text] [Related]
11. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole.
Suessbrich H; Waldegger S; Lang F; Busch AE
FEBS Lett; 1996 Apr; 385(1-2):77-80. PubMed ID: 8641472
[TBL] [Abstract][Full Text] [Related]
12. A comparison of Cetirizine, Ebastine, Epinastine, Fexofenadine, Terfenadine, and Loratadine versus placebo in suppressing the cutaneous response to histamine.
Grant JA; Danielson L; Rihoux J; DeVos C
Int Arch Allergy Immunol; 1999; 118(2-4):339-40. PubMed ID: 10224437
[No Abstract] [Full Text] [Related]
13. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
Wiseman LR; Faulds D
Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
[TBL] [Abstract][Full Text] [Related]
14. Epinastine, a nonsedating histamine H1 receptor antagonist, has a negligible effect on HERG channel.
Chachin M; Katayama Y; Yamada M; Horio Y; Ohmura T; Kitagawa H; Uchida S; Kurachi Y
Eur J Pharmacol; 1999 Jun; 374(3):457-60. PubMed ID: 10422790
[TBL] [Abstract][Full Text] [Related]
15. Blockade of HERG and Kv1.5 by ketoconazole.
Dumaine R; Roy ML; Brown AM
J Pharmacol Exp Ther; 1998 Aug; 286(2):727-35. PubMed ID: 9694927
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research.
Gelfand EW; Appajosyula S; Meeves S
Curr Med Res Opin; 2004 Jan; 20(1):73-81. PubMed ID: 14741075
[TBL] [Abstract][Full Text] [Related]
18. Effects of rupatadine, a new dual antagonist of histamine and platelet-activating factor receptors, on human cardiac kv1.5 channels.
Caballero R; Valenzuela C; Longobardo M; Tamargo J; Delpón E
Br J Pharmacol; 1999 Nov; 128(5):1071-81. PubMed ID: 10556945
[TBL] [Abstract][Full Text] [Related]
19. Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels.
Delpón E; Valenzuela C; Gay P; Franqueza L; Snyders DJ; Tamargo J
Cardiovasc Res; 1997 Aug; 35(2):341-50. PubMed ID: 9349397
[TBL] [Abstract][Full Text] [Related]
20. Studies of nonsedative antihistamines. II. Assessment of its antihistaminic potency.
Aparicio S; Granel C; Randazzo L; Valencia M; Olivé Pérez A
Allergol Immunopathol (Madr); 1992; 20(5):207-10. PubMed ID: 1363340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
